Royal Marsden NHS Foundation Trust
- Country
- 🇬🇧United Kingdom
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Oncotype DX DCIS: Impact on Radiotherapy Decision Making
- Conditions
- Breast Cancer
- Interventions
- Diagnostic Test: ONCOTYPE DX DCIS test
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 78
- Registration Number
- NCT06046664
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom
Sepsis in Oncology Patients
- Conditions
- Sepsis in Cancer Patients
- Interventions
- Other: No intervention
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 180
- Registration Number
- NCT06046677
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom
Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients
- Conditions
- Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
- First Posted Date
- 2023-08-31
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 170
- Registration Number
- NCT06019676
- Locations
- 🇬🇧
The Royal Marsden Hospital, Sutton, Surrey, United Kingdom
🇬🇧Buckinghamshire Healthcare NHS Trust, Aylesbury, United Kingdom
🇬🇧Northern Ireland Cancer Centre, Belfast Health & Social Care Trust, Belfast, United Kingdom
Fat Grafting for Vaginal Stenosis in Gynaelogical Cancer
- Conditions
- Cervical Cancer
- Interventions
- Procedure: Fat Graft
- First Posted Date
- 2023-08-29
- Last Posted Date
- 2023-10-05
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 8
- Registration Number
- NCT06015360
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom
Predicting Radiotherapy Response and Toxicities in Soft Tissue Sarcoma of the Extremities - Cohort B
- Conditions
- Soft Tissue Sarcoma of the Extremities
- First Posted Date
- 2023-08-07
- Last Posted Date
- 2023-08-07
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 150
- Registration Number
- NCT05978024
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom
🇬🇧University College London, London, United Kingdom
🇬🇧Addenbrooke's Hospital, Cambridge, United Kingdom
Single and Combined Modality Trans-Oral Robotic Surgery in Early Oropharyngeal Cancer
- Conditions
- Cancer Head Neck
- Interventions
- Genetic: Molecular AnalysisOther: Radiomic/ Morphological analysis
- First Posted Date
- 2023-07-06
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 250
- Registration Number
- NCT05933889
- Locations
- 🇬🇧
The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom
EVEREST-HN 1: EVolution of a patiEnt-REported Symptom-based Risk Stratification sySTem
- Conditions
- Head and Neck Cancer
- Interventions
- Other: No intervention.
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2023-10-03
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 165
- Registration Number
- NCT05909020
- Locations
- 🇬🇧
Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
🇬🇧Luton & Dunstable University Hospital, Luton, United Kingdom
🇬🇧Oxford NHS Foundation Trust, Oxford, United Kingdom
IReC-Bio and IReC Registry
- Conditions
- Head Cancer Neck
- First Posted Date
- 2023-06-02
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 10000000
- Registration Number
- NCT05885490
RDC Biomarker Study
- Conditions
- Cancer
- First Posted Date
- 2023-05-25
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 1000
- Registration Number
- NCT05876676
- Locations
- 🇬🇧
Aneurin Bevan University Local Health Board, Abergavenny, United Kingdom
🇬🇧Glan Clwyd, Bodelwyddan, United Kingdom
🇬🇧Harrogate and District NHS Foundation Trust, Harrogate, United Kingdom
A Study Comparing Urolift and TURP Ahead of Radiotherapy in Men With Urinary Symptoms Secondary to Prostate Enlargement
- Conditions
- Prostate Cancer
- Interventions
- Procedure: UroLiftProcedure: TURP
- First Posted Date
- 2023-05-03
- Last Posted Date
- 2023-09-01
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 45
- Registration Number
- NCT05840549
- Locations
- 🇬🇧
St Georges University Hospital, London, Lon, United Kingdom
🇬🇧The Royal Marsden NHS Foundation Trust, London, United Kingdom
🇬🇧Kathie Wong, Carlisle, United Kingdom